Biography:Mireille Gillings
Mireille Gillings | |
|---|---|
 Mireille Gillings | |
| Born | Montreal , Quebec, Canada |
| Nationality | Canadian |
| Education |
|
| Occupation | neurobiologist and entrepreneur |
| Spouse(s) | Dennis Gillings (m. 2012) |
Mireille Gingras Gillings (born 1971) is a US-based Canadian neurobiologist and entrepreneur. She founded HUYA Bioscience International, a biotech consulting firm in 2004, and is the San Diego, California company's CEO and Executive Chair. The company has offices in Pudong, Shanghai, China.[1][2]
In 2010 Gillings' interest in China as a source of "research-intensive, expensive-to-develop medicines that are the stuff of patents and high profit margins" attracted the interest of Fortune magazine.[3]
Born in Montreal , Quebec, Gillings earned her PhD from Radboud University Nijmegen and has held postdoctoral fellowships at Bordeaux University in France and The Scripps Research Institute in La Jolla, California. She received her bachelor's degree from Montréal's Concordia University.[4]
Also one of the founders of MIR3,[5] she is a "serial entrepreneur" as she has described herself.[6] Gillings is at least functional in several languages, including Mandarin, in addition to her native French.[7]
Gillings has articulated five points of advice for women who want to succeed in biotechnology as a male-dominated profession:[8]
- - 1. Commit to building and growing your career
- - 2. Know your industry, and look for opportunities that would play to women’s strengths
- - 3. Move away from your comfort zone when networking
- - 4. Maintain a balance between drive and patience
- - 5. Speak directly and with confidence
Personal life
In 2012, she married Dennis Gillings in Hawaii.[9]
References
- ↑ Welcome Message from CEO and founder Mireille Gillings, PhD (accessed 6 November 2010)
- ↑ Poh, Alissa (13 November 2008). "HUYA: A conduit between Chinese pharma and US clinical trials". PharmaWeek. http://www.ecliniqua.com/PharmaWeek_Article.aspx?id=84900&LangType=1033. Retrieved 6 November 2010.
- ↑ Powell, Bill (15 November 2010). "Biotech pioneers: How two unlikely partners plan to unleash China's young pharma industry". Fortune 182 (8): pp. 49–50, 52. http://tech.fortune.cnn.com/2010/11/05/chinas-biotech-pioneers/?section=money_topstories. Retrieved 6 November 2010. The quotation appears on p. 50.
- ↑ "Executive Team - HUYA Bioscience International". http://www.huyabio.com/Team/ManagementTeam.aspx. Retrieved 14 June 2017.
- ↑ HUYA profile on Bloomberg Business Week (accessed 6 November 2010); see also the MIR3 site
- ↑ Dolgin, Elie (June 2009). "Year of the compound: Will a novel codevelopment model open up China's drug discovery platform?". Scientist 23 (6): p. 57. http://www.the-scientist.com/article/print/55717. Retrieved 6 November 2010. The article explains that the name HUYA comes from the "Chinese abbreviations for Shanghai (Hù) and Asia (Yà)"; the name is pronounced in English like WHO YA with equal stress on both syllables (/'hu·'ja/).
- ↑ David, Gollaher; Gingras, Mirielle (9 February 2010). "HUYA Bioscience International". CHI: Advancing California Biomedical Research and Innovation. http://californiahealthcareinstitute.blogspot.com/2010/02/huya-bioscience-international.html. Retrieved 6 November 2010.
- ↑ Wilson, Elizabeth. "How to establish yourself in a male-dominated field: biotechnology". Women Entrepreneur. http://excelle.monster.com/benefits/articles/1860-how-to-establish-yourself-in-a-male-dominated-field. Retrieved 8 November 2010.
- ↑ Gibson, Dale (2012-09-07). "Gillings remarries; new bride heads California pharma". http://www.bizjournals.com/triangle/print-edition/2012/09/07/gillings-remarries-new-bride-heads.html.
 |
